Advertisement

Archives of Pharmacal Research

, Volume 31, Issue 9, pp 1160–1165 | Cite as

Morin protects acute liver damage by carbon tetrachloride (CCl4) in rat

  • Hee Seung Lee
  • Kyung-Hee Jung
  • Sang-Won Hong
  • In-Suh Park
  • Chongmu Lee
  • Hyo-Kyung Han
  • Don-Haeng Lee
  • Soon-Sun HongEmail author
Research Articles Drug Efficacy and Safety

Abstract

The purpose of this study was to investigate possible beneficial effects of morin on CCl4-induced acute hepatotoxicity in rats. Rats received a single dose of CCl4 (150 μL/100 g 1:1 in corn oil). Morin treatment (20 mg/kg) was given at 48, 24, and 2 h before CCl4 administration. CCl4 challenge elevated serum alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) levels, but these effects were prevented by the pretreatment of rats with morin. To identify the mechanism of protective activity of morin in CCl4-induced hepatotoxicity in rats, we investigated expressions of tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and inducible nitric oxide (iNOS). The expressions of TNF-α, IL-1β, IL-6, and iNOS were increased by CCl4 treatment and increased expressions of those were decreased by morin. These findings suggest that morin prevents acute liver damage by inhibiting the production of TNF-α, IL-1β, IL-6, and iNOS.

Key words

Morin Antioxidant Carbon tetrachloride (CCl4Hepatic toxicity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chamulitrat, W., Blazka, M. E., Jordan, S. J., Luster, M. I., and Mason, R. P., Tumor necrosis factor-alpha and nitric oxide production in endotoxin-primed rats administered carbon tetrachloride. Life Sci, 57, 2273–2280 (1995).PubMedCrossRefGoogle Scholar
  2. Dong, W., Simeonova, P. P., Gallucci, R., Matheson, J., Flood, L., Wang, S., Hubbs, A., and Luster, M. I., Toxic metals stimulate inflammatory cytokines in hepatocytes through oxidative stress mechanisms. Toxicol Appl Pharmacol, 151, 359–366 (1998).PubMedCrossRefGoogle Scholar
  3. Drotman, R. B. and Lawhorn, G. T., Serum enzymes as indicators of chemically induced liver damage. Drug Chem Toxicol, 1, 163–171 (1978).PubMedCrossRefGoogle Scholar
  4. Edwards, M. J., Keller, B. J., Kauffman, F. C., and Thurman, R. G., The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol Appl Pharmacol, 119, 275–279 (1993).PubMedCrossRefGoogle Scholar
  5. Fang, S. H., Hou, Y. C., Chang, W. C., Hsiu, S. L., Chao, P. D., and Chiang, B. L., Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci, 74, 743–756 (2003).PubMedCrossRefGoogle Scholar
  6. Galvez, J., Coelho, G., Crespo, M. E., Cruz, T., Rodriguez-Cabezas, M. E., Concha, A., Gonzalez, M., and Zarzuelo, A., Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat. Aliment Pharmacol Ther, 15, 2027–2039 (2001).PubMedCrossRefGoogle Scholar
  7. Gutteridge, J. M., and Halliwell, B., Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci, 899, 136–147 (2000).PubMedGoogle Scholar
  8. Hierholzer, C., Harbrecht, B., Menezes, J. M., Kane, J., MacMicking, J., Nathan, C. F., Peitzman, A. B., Billiar, T. R., and Tweardy, D. J., Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med, 187, 917–928 (1998).PubMedCrossRefGoogle Scholar
  9. Hishinuma, I., Nagakawa, J., Hirota, K., Miyamoto, K., Tsukidate, K., Yamanaka, T., Katayama, K., and Yamatsu, I., Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice. Hepatology, 12, 1187–1191 (1990).PubMedCrossRefGoogle Scholar
  10. Kawabata, K., Tanaka, T., Honjo, S., Kakumoto, M., Hara, A., Makita, H., Tatematsu, N., Ushida, J., Tsuda, H., and Mori, H., Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis. Int J Cancer, 83, 381–386 (1999).PubMedCrossRefGoogle Scholar
  11. Kuo, H. M., Chang, L. S., Lin, Y. L., Lu, H. F., Yang, J. S., Lee, J. H., and Chung, J. G., Morin inhibits the growth of human leukemia HL-60 cells via cell cycle arrest and induction of apoptosis through mitochondria dependent pathway. Anticancer Res, 27, 395–405 (2007).PubMedGoogle Scholar
  12. Laughton, M. J., Evans, P. J., Moroney, M. A., Hoult, J. R., and Halliwell, B., Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol, 42, 1673–1681 (1991).PubMedCrossRefGoogle Scholar
  13. Li, J., and Billiar, T. R., Nitric Oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol, 276, G1069–G1073 (1999).PubMedGoogle Scholar
  14. Lutz, L. M., Glende, E. A., Jr., and Recknagel, R. O., Protection by diethyldithiocarbamate against carbon tetrachloride lethality in rats and against carbon tetrachloride-induced lipid peroxidation in vitro. Biochem Pharmacol, 22, 1729–1734 (1973).PubMedCrossRefGoogle Scholar
  15. Manna, S. K., Aggarwal, R. S., Sethi, G., Aggarwal, B. B., and Ramesh, G. T., Morin (3,5,7,2′,4′-Pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis. Clin Cancer Res, 13, 2290–2297 (2007).PubMedCrossRefGoogle Scholar
  16. Mizuoka, H., Shikata, N., Yang, J., Takasu, M., Inoue, K., and Tsubura, A., Biphasic effect of colchicine on acute liver injury induced by carbon tetrachloride or by dimethylnitrosamine in mice. J Hepatol, 31, 825–833 (1999).PubMedCrossRefGoogle Scholar
  17. Ocete, M. A., Galvez, J., Crespo, M. E., Cruz, T., Gonzalez, M., Torres, M. I., and Zarzuelo, A., Effects of morin on an experimental model of acute colitis in rats. Pharmacology, 57, 261–270 (1998).PubMedCrossRefGoogle Scholar
  18. Rao, P. S., Mangipudy, R. S., and Mehendale, H. M., Tissue injury and repair as parallel and opposing responses to CCl4 hepatotoxicity: a novel dose-response. Toxicology, 118, 181–193 (1997).PubMedCrossRefGoogle Scholar
  19. Shito, M., Balis, U. J., Tompkins, R. G., Yarmush, M. L., and Toner, M., A fulminant hepatic failure model in the rat: involvement of interleukin-lbeta and tumor necrosis factor-alpha. Dig Dis Sci, 46, 1700–1708 (2001).PubMedCrossRefGoogle Scholar
  20. Simpson, K. J., Lukacs, N. W., Colletti, L., Strieter, R. M., and Kunkel, S. L., Cytokines and the liver. J Hepatol, 27, 1120–1132 (1997).PubMedCrossRefGoogle Scholar
  21. Steel, D. M. and Whitehead, A. S., The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today, 15, 81–88 (1994).PubMedCrossRefGoogle Scholar
  22. Thompson, D., Whicher, J. T., and Banks, R. E., Acute phase reactants in predicting disease outcome. Baillieres Clin Rheumatol, 6, 393–404 (1992).PubMedCrossRefGoogle Scholar
  23. Tiegs, G., Wolter, M., and Wendel, A., Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol, 38, 627–631 (1989).PubMedCrossRefGoogle Scholar
  24. Wu, T. W., Zeng, L. H., Wu, J., and Fung, K. P., Morin: a wood pigment that protects three types of human cells in the cardiovascular system against oxyradical damage. Biochem Pharmacol, 47, 1099–1103 (1994).PubMedCrossRefGoogle Scholar
  25. Wu, T. W., Zeng, L. H., Wu, J., and Fung, K. P., Morin hydrate is a plant-derived and antioxidant-based hepatoprotector. Life Sci, 53, PL213-8 (1993).Google Scholar
  26. Yang, S. Q., Lin, H. Z., Yin, M., Albrecht, J. H., and Diehl, A. M., Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. Am J Physiol, 275, G696–G704 (1998).PubMedGoogle Scholar
  27. Yu, Z., Fong, W. P., and Cheng, C. H., The dual actions of morin (3,5,7,2′,4′-pentahydroxyflavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activity. J Pharmacol Exp Ther, 316, 169–175 (2006).PubMedCrossRefGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2008

Authors and Affiliations

  • Hee Seung Lee
    • 1
  • Kyung-Hee Jung
    • 1
  • Sang-Won Hong
    • 1
  • In-Suh Park
    • 1
  • Chongmu Lee
    • 1
    • 2
  • Hyo-Kyung Han
    • 1
    • 3
  • Don-Haeng Lee
    • 1
  • Soon-Sun Hong
    • 1
    Email author
  1. 1.Clinical Research Center, College of MedicineInha UniversityIncheonKorea
  2. 2.Department of Materials Science and EngineeringInha UniversityIncheonKorea
  3. 3.College of PharmacyChosun UniversityGwangjuKorea

Personalised recommendations